论文信息 - A first-in-human phase Ib study to evaluate the MEK inhibitor GDC-0973, combined with the pan-PI3K inhibitor GDC-0941, in patients with advanced solid tumors. - 字舞流文

A first-in-human phase Ib study to evaluate the MEK inhibitor GDC-0973, combined with the pan-PI3K inhibitor GDC-0941, in patients with advanced solid tumors.

M. Belvin | G. Shapiro | P. LoRusso | E. Kwak | J. Bendell | L. Musib | S. Pandya | Mary R. Gates | A. Crespigny | Cheryl Jones | I. Chan | M. McKenzie